$PFE 
Pfizer CEO  Bourla said, "Given the continued breadth of. Consequently, we remain highly confident in our ability to deliver, following the closing of the proposed combination of Upjohn with Mylan N.V., a compound annual growth rate for revenues of at least 6% through 2025.